"With new AI legislation, I expect a renewed focus on 'old AI.' Additionally, we are likely to observe more instances of AI shortcomings, similar to UnitedHealth's algorithmic care denials. These kinds of mishaps often won't be intentional, but like long-term side effects of medications, they will emerge gradually as AI gets used more widely. I'm optimistic about AI's role in healthcare access. I see a shift from excitement about generative AI scribes to applications in Workforce Planning, where AI will enable specialist-patient matching based on case complexity, saving time and increasing capacity. In combination with Remote Healthcare, the 'hospital at home' and 'virtual wards' models will reduce hospital overcrowding and improve care access. I anticipate breakthroughs in biotech with generative AI, including the discovery of new drug molecules, treatments, and targeted patient populations for existing drugs."